Feb 8th 2023 - Mar 22nd 2023
great for long term value.
$BABA even the bears here believe in the long term... See more
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$AVXL Long Term Bullish
We are excited about the data and plan to submit t... See more
great for long term value.
$BABA even the bears here believe in the long term of baba stay strong bulls
$BABA seems like a good day to buy long term calls.
$BABA china standing up for themselves is a very long term bullish sign.
The covid reopening after 3 years is big tailwind with all support from Govt in terms of monetary/fiscal policy.
Longer term yes it's a buy
$BABA looks to be forming a longer term bottom here (inverse h s) I’m liking this chart
$BABA this will probably do well long term once Russia and China merge together.
Positive earnings setup long term growth.
$BABA long term this a gift !
Certainly will in the long term.
I am a long term holder.
Like I said before, LONG TERM INVESTOR!!! 🤔
$GNUS If this goes back above $1.00 in time, this stock is well worth holding long term. Very!!
but the short term trend is positive.
$GNUS what i am appreciating is all of the quiet long term old bulls i see that are posting today amongst the confusion and defending our Genius
This is Very Healthy for our Long Term goal! !
$GNUS short term chart looks VERY strong.
EASY MONEY even if you only want to play here for a couple weeks( im long term) just saying, wake up and stop complaining how much you lost because everyone of us is in a position for an easy win over the next six weeks.
$GNUS short term chart looks quite strong.
$AVXL Long Term Bullish
We are excited about the data and plan to submit the data for publication and peer reviewed medical journal in the near term.
It would be good Long Term Care insurance for me.
I'm looking forward to seeing the long term AD data on ANVS and have the feeling it's going to end up being the best in class AD treatment as well.
but the short term trend is positive.
its on the top of your near term catalysts.
I am cautiously optimistic in the short term.
$BIVI wow nothing in terms of quality of drug has changed.. what a buying opportunity to build a long term holding!!
Gonna be a great long term hold!
This is sitting on long term trend lines.
